YKT6 expression, exosome release, and survival in non-small cell lung cancer

Oncotarget

Volumn 7, Issue 32, 2016, Pages 51515-51524

  Ruiz Martinez, Marc ^a   Navarro, Alfons ^a   Marrades, Ramón M ^a   Viñolas, Nuria ^a   Santasusagna, Sandra ^a   Muñoz, Carmen ^a   Ramírez, Josep ^a   Molins, Laureano ^a   Monzo, Mariano ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Exosomes; MiR 134; MiR 135b; NSCLC; YKT6

Indexed keywords

DOCETAXEL; PROTEIN YKT6; SMALL INTERFERING RNA; SNARE PROTEIN; UNCLASSIFIED DRUG; MICRORNA; SYNAPTOBREVIN; YKT6 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME INHIBITION; EXOSOME; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; ONCOGENE K RAS; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; SURVIVAL RATE; TP53 GENE; TRANSMISSION ELECTRON MICROSCOPY; VALIDATION STUDY; WESTERN BLOTTING; A-549 CELL LINE; ADULT; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

A549 CELLS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CELL SURVIVAL; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; R-SNARE PROTEINS;

EID: 84982286165     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9862     Document Type: Article

References (33)

1. Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication. Current opinion in cell biology. 2009; 21:575-581.
2. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology. 2007; 9:654-659.
3. Webber J, Yeung V, Clayton A. (2015). Extracellular vesicles as modulators of the cancer microenvironment. Seminars in cell & developmental biology: Elsevier), pp. 27-34.
4. Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang W, Steadman R, Wymant J, Jones AT, Kynaston H, Mason MD. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene. 2014.
5. Taylor DD, Gercel-Taylor C. (2011). Exosomes/ microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Seminars in immunopathology: Springer), pp. 441-454.
6. Beckler MD, Higginbotham JN, Franklin JL, Ham A-J, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Molecular & Cellular Proteomics. 2013; 12:343-355.
7. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM. Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET. Nature medicine. 2012; 18:883-891.
8. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. Traffic. 2002; 3:321-330.
9. Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, Ostrowski M, Théry C. Rab27a supports exosome-dependent and-independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer research. 2012; 72:4920-4930.
10. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature cell biology. 2010; 12:19-30.
11. Hsu C, Morohashi Y, Yoshimura S-I, Manrique-Hoyos N, Jung S, Lauterbach MA, Bakhti M, Grønborg M, Möbius W, Rhee J. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. The Journal of cell biology. 2010; 189:223-232.
12. Li W, Hu Y, Jiang T, Han Y, Han G, Chen J, Li X. Rab27A regulates exosome secretion from lung adenocarcinoma cells A549: involvement of EPI64. APMIS. 2014; 122:1080-1087.
13. Gordon DE, Bond LM, Sahlender DA, Peden AA. A targeted siRNA screen to identify SNAREs required for constitutive secretion in mammalian cells. Traffic. 2010; 11:1191-1204.
14. Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active Wnt proteins are secreted on exosomes. Nature cell biology. 2012; 14:1036-1045.
15. Kluger HM, Kluger Y, Gilmore-Hebert M, DiVito K, Chang JT, Rodov S, Mironenko O, Kacinski BM, Perkins AS, Sapi E. cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model. Laboratory investigation. 2004; 84:320-331.
16. Ooe A, Kato K, Noguchi S. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers. Breast cancer research and treatment. 2007; 101:305-315.
17. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L, Committee IAftSoLCIS. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. Journal of thoracic oncology. 2007; 2:706-714.
18. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-233.
19. Silva J, Garcia V, Rodriguez M, Compte M, Cisneros E, Veguillas P, Garcia J, Dominguez G, Campos-Martin Y, Cuevas J. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes, Chromosomes and Cancer. 2012; 51:409-418.
20. Yamashita T, Kamada H, Kanasaki S, Maeda Y, Nagano K, Abe Y, Inoue M, Yoshioka Y, Tsutsumi Y, Katayama S. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2013; 68:969-973.
21. Söllner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993; 362:318-324.
22. Weber T, Zemelman BV, McNew JA, Westermann B, Gmachl M, Parlati F, Söllner TH, Rothman JE. SNAREpins: minimal machinery for membrane fusion. Cell. 1998; 92:759-772.
23. McNew JA, Søgaard M, Lampen NM, Machida S, Ye RR, Lacomis L, Tempst P, Rothman JE, Söllner TH. Ykt6p, a prenylated SNARE essential for endoplasmic reticulum-Golgi transport. Journal of Biological Chemistry. 1997; 272:17776-17783.
24. Volchuk A, Ravazzola M, Perrelet A, Eng WS, Di Liberto M, Varlamov O, Fukasawa M, Engel T, Söllner TH, Rothman JE. Countercurrent distribution of two distinct SNARE complexes mediating transport within the Golgi stack. Molecular biology of the cell. 2004; 15:1506-1518.
25. Beyer S, Kristensen MM, Jensen KS, Johansen JV, Staller P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. Journal of Biological Chemistry. 2008; 283:36542-36552.
26. Dong W-W, Mou Q, Chen J, Cui J-T, Li W-M, Xiao W-H. Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J Gastroenterol. 2012; 18:1806-1813.
27. Lin C-W, Chang Y-L, Chang Y-C, Lin J-C, Chen C-C, Pan S-H, Wu C-T, Chen H-Y, Yang S-C, Hong T-M. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nature communications. 2013; 4:1877.
28. Azad FM, Naeli P, Malakootian M, Baradaran A, Tavallaei M, Ghanei M, Mowla S. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors. Gene. 2016; 577:221-226.
29. Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, Hendrix A, Lamy P, Dagnaes-Hansen F, Rasmussen MH. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer research. 2014; 74:5758-5771.
30. Zhao H, Wang Q, Wang X, Zhu H, Zhang S, Wang W, Wang Z, Huang J. Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer. Pancreas. 2016; 45:204-210.
31. Bao J, Ni Y, Qin H, Xu L, Ge Z, Zhan F, Zhu H, Zhao J, Zhou X, Tang X. Rab27b Is a Potential Predictor for Metastasis and Prognosis in Colorectal Cancer. Gastroenterology research and practice. 2014; 2014.
32. Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology. 2006:3.22. 21-23.22. 29.
33. Diaz T, Navarro A, Ferrer G, Gel B, Gaya A, Artells R, Bellosillo B, Garcia-Garcia M, Serrano S, Martínez A. Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis. PloS one. 2011; 6:e18856.